SUNY Upstate Medical Center

Syracuse, New York 13210

1 studies enrolling now · 31 studies all time

What they study most

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Anesthesia, Brain Edema, Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Primary

Studies at this site

• Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — Recruiting now
• A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab — Completed
• A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation — Running, not enrolling
• A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab — Completed
• CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old — Running, not enrolling
• Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling
• P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation — Running, not enrolling
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) — Completed
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• Pediatric Chronic Rhinosinusitis in Asthmatic Children — Withdrawn before enrolling
• informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir — Completed
• Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia — Completed
• Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy — Completed
• A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• The EPIC Observational Study — Completed
• Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III — Completed
• Use of Formula Fortified With DHA in Infants With Cystic Fibrosis — Completed
• Steroid Injections Given at the "Level of MRI Pathology" Versus at the "Level of Clinical Symptoms" to See if One is More Effective Than the Other. — Withdrawn before enrolling
• A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC) — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed